In Episode 47 of the Game Over: c*ncer, hosts Dana Nichols and Val Solomon sit down with Dr. Kira Bona, a pediatric oncologist interested in social determinants of health for kids in cancer treatment. Her research found that 1 out of 3 childhood cancer patients in the US are experiencing poverty at the time of their diagnosis. So, her team could positively impact 1 in 3 children in the middle of their cancer fight. She shares where she is in this process on her episode of the Game Over: c*ncer podcast.
You can watch her episode here: Game Over: c*ncer EP47: Dr. Kira Bona
1. Defining “Access” Beyond Geography
The episode opens by expanding the meaning of access: not just getting kids to clinical trials, but ensuring they achieve survival and quality-of-life outcomes once there.
2. Dr. Kira Bona’s Origin Story
Kira Bona explains her work began from real clinical observations of families struggling with issues like transportation, food, and utility insecurities while their child undergoes cancer treatment.
3. The “Blind Spot” in Pediatric Oncology
For decades, the field assumed standardized care through clinical trials eliminated disparities. This assumption created a major blind spot where no one was measuring the impact of poverty on outcomes.
4. The Breakthrough Finding
Reanalyzing clinical trial data revealed a striking reality:
Children from low-income households were nearly twice as likely to relapse or die, even when receiving the same top-tier treatment as their counterparts.
5. The Scale of the Problem
Research showed that 1 in 3 children with cancer face poverty-related challenges (income, food insecurity, housing instability), making this one of the largest opportunities to improve outcomes in pediatric cancer.
6. A New Research Framework (“Drugging Poverty”)
Dr. Bona’s team applies a cancer-research model to social factors:
- Measure poverty-related risks
- Understand mechanisms (behavioral + biological)
- Intervene immediately (without waiting for perfect understanding)
This reframes poverty as a treatable risk factor, not just a background issue.
7. Hope: First Health Equity Clinical Trial
The field has reached a major milestone: A randomized clinical trial testing an intervention targeting poverty is now underway. Even if it fails, it establishes a repeatable model for future solutions.
Why It Matters
CKc is inspired by innovative researchers like Dr. Kira Bona. Her work is changing the conversation, and CKc is committed to amplifying that progress. By educating and engaging our community, CKc helps shine a light on breakthrough ideas, so more families, supporters, and advocates can be part of moving pediatric cancer research forward.
If you are as excited about Dr. Bona’s research as CKc is and want to join our fight, visit cannonballkidscancer.org to learn more, donate, or get involved.
Know a survivor or advocate whose story needs to be shared? Email us at info@cannonballkidscancer.org to nominate a guest!
